Skip to main content

Table 3 Univariated regression model between Lp-PLA 2 and cardiometabolic factors

From: Influence of obesity and cardiometabolic makers on lipoprotein-associated phospholipase A2 (Lp-PLA2) activity in adolescents: the healthy young cross-sectional study

 

Lp-PLA2

 

R2

P*

β

BMI, kg/m 2

0.038

0.003

0.195

WC, cm

0.073

0.000

0.270

Fat mass,%

0.034

0.004

0.186

TC, mg/dL

0.035

0.004

0.186

LDL-C, mg/dL

0.016

0.051

0.128

HDL-C, mg/dL

0.001

0.671

−0.028

TG, mg/dL

0.008

0.163

0.091

TG/HDL-C

0.007

0.199

0.084

LDL-C/HDL-C

0.010

0.121

0.121

TC/HDL-C

0.018

0.042

0.133

Non HDL-C

0.022

0.022

0.149

HDL-C/ApoAI

0.001

0.585

0.036

Apo AI, mg/dL

0.019

0.038

−0.137

Apo B, mg/dL

0.082

0.000

0.293

Apo B/Apo AI

0.118

0.000

0.343

LDL-C/ApoB

0.000

0.775

−0.019

LDL(−), mg/mL

0.001

0.706

0.025

Anti LDL(−), mg/mL

0.013

0.078

−0.115

HDL size , nm

0.085

0.000

−0.291

Insulin, uU/mL

0.039

0.002

0.198

Glucose, mg/dL

0.019

0.034

0.138

HOMA-IR

0.047

0.001

0.216

  1. BMI, Body Mass Index; WC, waist circumference, HOMA-IR, homeostasis model assessment of insulin resistance; TC, total cholesterol; TG, triglycerides; LDL, low density lipoprotein; HDL, high density lipoprotein.
  2. Variables in log form, except for percentages. *Significant level (P < 0.05).
Back to article page

Lipids in Health and Disease

ISSN: 1476-511X